Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

172 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility Acute Myeloid Leukemia NCT00322673

- 18-02-16 - 1 Formulier, 2 Itemgroepen, 12 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Study of XL999 in Patients With Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00322673

Eligibility Acute Myeloid Leukemia NCT00242515

- 18-02-16 - 1 Formulier, 2 Itemgroepen, 17 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS); ODM derived from: https://clinicaltrials.gov/show/NCT00242515

Eligibility Acute Myeloid Leukemia NCT00279773

- 18-02-16 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00279773

Eligibility Acute Myeloid Leukemia NCT00260832

- 18-02-16 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Trial of Decitabine in Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00260832

Eligibility Acute Myeloid Leukemia NCT00188136

- 17-02-16 - 1 Formulier, 2 Itemgroepen, 12 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Early Allogeneic Blood Stem Cell Transplantation in High-Risk Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00188136

Eligibility Acute Myeloid Leukemia DRKS00003818 NCT00151242 - Eligibility Acute Myeloid Leukemia NCT00151242

- 17-02-16 - 1 Formulier, 2 Itemgroepen, 13 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00151242

Eligibility Acute Myeloid Leukemia NCT00151255

- 17-02-16 - 1 Formulier, 2 Itemgroepen, 12 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00151255

Eligibility Acute Myeloid Leukemia NCT00093990

- 17-02-16 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00093990

Eligibility Acute Myeloid Leukemia NCT00150878

- 17-02-16 - 1 Formulier, 2 Itemgroepen, 16 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission; ODM derived from: https://clinicaltrials.gov/show/NCT00150878

Eligibility Acute Myeloid Leukemia NCT00081822

- 16-02-16 - 1 Formulier, 2 Itemgroepen, 18 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00081822

Eligibility Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome NCT01420926

- 16-02-16 - 1 Formulier, 1 Itemgroep, 5 Data-elementen, 1 Taal
Itemgroep: Inclusion Criteria
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01420926

Eligibility Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome NCT01238211

- 16-02-16 - 1 Formulier, 1 Itemgroep, 11 Data-elementen, 1 Taal
Itemgroep: Inclusion Criteria
Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01238211

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial